Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile
AJ Scheen - Expert Opinion on Drug Safety, 2024 - Taylor & Francis
Introduction Patients with type 2 diabetes (T2DM) are at high risk of atherosclerotic
cardiovascular disease (ASCVD) and cardiovascular death. Cardiovascular protection is a …
cardiovascular disease (ASCVD) and cardiovascular death. Cardiovascular protection is a …
[HTML][HTML] Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
AJ Scheen - Diabetes Epidemiology and Management, 2023 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF) and chronic kidney
disease (CKD) are major complications of type 2 diabetes (T2DM). The objectives of …
disease (CKD) are major complications of type 2 diabetes (T2DM). The objectives of …
[HTML][HTML] New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
K Chatzianagnostou, M Gaggini… - International Journal of …, 2024 - mdpi.com
Although good glycemic control in patients with type 2 diabetes (T2D) can prevent
cardiovascular complications, many diabetic patients still have poor optimal control. A new …
cardiovascular complications, many diabetic patients still have poor optimal control. A new …
[HTML][HTML] Paradoxical real-life underuse of GLP-1 receptor agonists in type 2 diabetes patients with atherosclerotic cardiovascular disease: Underuse of GLP-1RAs in …
AJ Scheen - Diabetes Epidemiology and Management, 2024 - Elsevier
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce the risk of
cardiovascular (CV) complications in patients with type 2 diabetes (T2DM) and …
cardiovascular (CV) complications in patients with type 2 diabetes (T2DM) and …
Insulin Medication Trends in Diabetes Management: A Comprehensive USDDS Database Analysis
OE Okobi, OO Olasupo, AR Afolabi… - … of Advances in …, 2024 - asian.universityeprint.com
Background: Insulin medication trends in diabetes management have evolved significantly
over the past two decades, influenced by demographic factors and advancements in …
over the past two decades, influenced by demographic factors and advancements in …